Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

Carl J. Pepine, Peter F. Cohn, Prakash Deedwania, Robert S. Gibson, Eileen Handberg, James A. Hill, Elizabeth Miller, Ronald G. Marks, Udho Thadani

Circulation · 1994 · 340 citations · 25 references

DOIFull text

Open access

Abstract

Atenolol treatment reduced daily life ischemia and was associated with reduced risk for adverse outcome in asymptomatic and mildly symptomatic patients compared with placebo.

References

25